New Breakthrough in Alopecia Areata Treatment: Deuruxolitinib Shows Promising Results Overview of Deuruxolitinib Recent studies have illuminated the benefits of deuruxolitinib, a selective Janus Kinase (JAK)…
Significant Advances in Alopecia Areata Treatment Presented at EADV Congress MUMBAI, India & PRINCETON, N.J. – Sept. 26, 2024 – Sun Pharmaceutical Industries Limited has unveiled…
